文献速递妇科产科

子宫内膜和卵巢同期原发性双癌的临床病理及生存分析

[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2018-01-01

回顾性分析北京协和医院2000年1月至2018年5月63例经病理证实的子宫内膜和卵巢同期原发性双癌(SEOC)患者,总结其临床病理特征及预后因素。患者多为年轻、绝经前女性,总体预后较好,5年无进展生存率69%、5年总生存率80%。淋巴脉管间隙浸润、卵巢癌非子宫内膜样病理类型及卵巢癌分期高于Ⅰ期与更差生存相关。

要点

  • SEOC患者多为年轻、绝经前女性,总体预后较好,5年PFS 69%、5年OS 80%。
  • 淋巴脉管间隙浸润、卵巢癌非子宫内膜样类型、卵巢癌分期高于Ⅰ期与更差PFS相关。
  • 淋巴脉管间隙浸润和卵巢癌分期高于Ⅰ期与更差OS相关。

核心结论

  • SEOC患者通常较为年轻,多为绝经前女性,预后较好。
  • LVSI、卵巢癌为非子宫内膜样癌以及卵巢癌手术病理分期高于Ⅰ期是影响SEOC患者5年PFS的独立因素。
  • LVSI与卵巢癌手术病理分期高于Ⅰ期是影响SEOC患者5年OS的独立因素。

研究设计与样本

  • 回顾性分析2000年1月至2018年5月于中国医学科学院北京协和医院诊治并经病理检查证实的63例SEOC患者的临床病理资料。

主要发现

  • 诊断时年龄为(48.3±10.0)岁,BMI为(23.4±3.7)kg/m²;首诊症状为异常子宫出血者占73%(46/63),未绝经者占68%(43/63),未生育者占30%(19/63)。
  • 子宫内膜癌Ⅰ期占90%,G1~G2占81%,子宫内膜样癌占86%,无或浅肌层浸润占81%;卵巢癌Ⅰ期占70%,G1~G2占65%,子宫内膜样癌占62%,单侧受累占68%。
  • 全部患者接受手术,56例(89%)接受包括腹膜后淋巴清扫在内的分期手术,57例(90%)接受术后辅助治疗;中位随访48.0个月(2~176个月),复发8例(13%),复发中位时间38.5个月,死于肿瘤复发6例(10%)。
  • 5年PFS为69%,5年OS为80%。
  • 单因素分析显示LVSI、卵巢癌非子宫内膜样癌、卵巢癌分期高于Ⅰ期者5年PFS更差(P<0.05);LVSI、子宫内膜癌高病理分级、卵巢癌分期高于Ⅰ期者5年OS更差(P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To demonstrate the clinicopathological characteristics and determine the prognostic factors for women with synchronous primary endometrial and ovarian cancer (SEOC) . Methods: A retrospective analysis of 63 pathologically proven cases of SEOC diagnosed in Peking Union Medical College Hospital from January 2000 to May 2018 was carried out. Results: (1) Clinical features: mean age at diagnosis was (48.3±10.0) years, and the mean body mass index (BMI) was (23.4±3.7) kg/m(2). The most common presenting symptom was abnormal uterine bleeding with a ratio of 73% (46/63). Forty-three patients (68%, 43/63) were premenopausal, and 30% (19/63) were nulliparous. (2) Pathological features: for the endometrial cancer, 90% patients were diagnosed at stage Ⅰ, and 81% were low grade tumors (G(1)-G(2)). The histological type of endometrial cancer was mainly endometrioid carcinoma (86%) and majority (81%) of patients were proved without or with superficial myometrial invasion. For the ovarian cancer, 70% patients were diagnosed at stage Ⅰ and 65% were low grade tumors (G(1)-G(2)). Sixty-two percent of ovarian cancers were endometrioid carcinoma and 68% of patients had unilateral involvement of the ovaries. (3) Treatment and prognosis: all patients underwent surgery, of which 56 (89%) underwent staging surgery including retroperitoneal lymphadenectomy, and 57 (90%) received postoperative adjuvant therapy. The median follow-up time was 48.0 months (range, 2-176 months) , and 13% of the patients experienced tumor recurrence during the follow-up period. The median time to recurrence was 38.5 months, and 6 patients (10%) died of tumor recurrence. The 5-year progression-free survival (PFS) and 5-year overall survival (OS) for all patients were 69% and 80%, respectively. (4) Prognostic factors: univariate analysis showed that the presence of lymphovascular space invasion (LVSI) , non-endometrioid histology of ovarian cancer and stage of ovarian cancer above stage Ⅰ were associated with significantly worse PFS (P<0.05). LVSI, high grade of endometrial cancer, and above stage Ⅰ of ovarian cancer were associated with significantly worse OS (P<0.05). On multivariate analysis, LVSI, non-endometrioid type ovarian cancer and stage of ovarian cancer above stage Ⅰwere associated with significantly worse PFS (P<0.05). In addition, LVSI and stage of ovarian cancer above stage Ⅰ were also associated with significantly worse OS (P<0.05) . Conclusions: Women with SEOC are young, premenopausal and have a favorable overall prognosis. Presence of LVSI, non-endometrioid type ovarian cancer and stage of ovarian cancer above stage Ⅰ are independent prognostic factors for PFS, and stage of ovarian cancer above stage Ⅰare independent prognostic factors for OS. 目的: 探讨子宫内膜和卵巢同期原发性双癌(SEOC)患者的临床病理特征点及预后影响因素。 方法: 回顾性分析2000年1月—2018年5月于中国医学科学院北京协和医院诊治并经病理检查证实的63例SEOC患者的临床病理资料,探讨SEOC的治疗及预后,并对影响SEOC患者预后的相关因素进行分析。 结果: (1)临床特点:63例SEOC患者诊断时的年龄为(48.3±10.0)岁,体质指数(BMI)为(23.4±3.7)kg/m(2);首诊症状为异常子宫出血者占73%(46/63);未生育者占30%(19/63),未绝经者占68%(43/63)。(2)病理特点:SEOC中的子宫内膜癌主要为低手术病理分期(Ⅰ期占90%)、低病理分级(G(1)~G(2)占81%),病理类型以子宫内膜样癌为主(占86%),浸润深度以无或浅肌层浸润为主(占81%);SEOC中的卵巢上皮性癌(卵巢癌)主要为低手术病理分期(Ⅰ期占70%)、低病理分级(G(1)~G(2)占65%),病理类型以子宫内膜样癌为主(占62%),以卵巢单侧受累为主(占68%)。(3)治疗及预后:63例SEOC患者均接受了手术治疗,其中56例(89%)接受了包括腹膜后淋巴清扫在内的分期手术,57例(90%)接受了术后辅助治疗。中位随访时间为48.0个月(2~176个月),随访期间内复发8例(13%),复发的中位时间为38.5个月,死于肿瘤复发者6例(10%);SEOC患者的5年无进展生存率(PFS)为69%,5年总生存率(OS)为80%。(4)预后影响因素分析:单因素分析显示,淋巴脉管间隙浸润(LVSI)、卵巢癌为非子宫内膜样癌、卵巢癌手术病理分期高于Ⅰ期者的5年PFS更差(P<0.05),LVSI、SEOC中子宫内膜癌为高病理分级、SEOC中卵巢癌的手术病理分期高于Ⅰ期者的5年OS更差(P<0.05);多因素分析显示,LVSI、SEOC中卵巢癌的病理类型和手术病理分期为影响SEOC患者5年PFS的独立因素(P<0.05),LVSI、SEOC中卵巢癌的手术病理分期是影响SEOC患者5年OS的独立因素(P<0.05)。 结论: SEOC患者通常较为年轻,多为绝经前女性,预后较好。LVSI、卵巢癌为非子宫内膜样癌以及卵巢癌手术病理分期高于Ⅰ期是影响SEOC患者5年PFS的独立因素,而LVSI与卵巢癌手术病理分期高于Ⅰ期是影响SEOC患者5年OS的独立因素。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang Y, Yu M, Yang JX, et al. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 30585019. doi:10.3760/cma.j.issn.0529-567x.2018.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。